Decrease Obstructive Sleep Apnea (OSA) Sympathetic Tone : Impact of APAP vs CPAP (APAP-CPAP)
Primary Purpose
Sleep Apnea Syndromes
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Fixed CPAP
Auto-adjusting CPAP
Sponsored by
About this trial
This is an interventional other trial for Sleep Apnea Syndromes
Eligibility Criteria
Inclusion Criteria:
- patient with OSA (AHI ≥20 / h)
- patient with daytime sleepiness
- naive of any pressure treatment of OSA
- patient able to provide written informed consent
- not a vulnerable person or legally protected adult.
Exclusion Criteria:
- pregnancy
- Person deprived of liberty or subject to a legal protection measure.
- Patient with serious heart failure (According to investigator judgment)
- patient with central sleep apnea index above 20% of AHI
- Patient with a significant intercurrent pathology that can influence the results. (According to investigator judgment).
Sites / Locations
- CHU Grenoble AlpesRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Fixed CPAP
Auto-adjusting CPAP
Arm Description
CPAP always deliver air with the same pressure
Auto-CPAP changes the pressure delivered depending on events detected at any time (apnea, hypopnea …) and applies the lowest pressure required to eliminate events.
Outcomes
Primary Outcome Measures
Sympathetic tone (MSNA)
Change from Baseline Sympathetic tone at 1 months
Secondary Outcome Measures
24 hours Systolic Blood pressure (AMBP)
Change from Baseline in 24 hours ambulatory systolic blood pressure
Systolic Blood pressure (office)
Clinical BP on 3 occasions, SBP and BP will be assessed. Mean BP calculated as DBP+1/3(SBP-DBP)
Diastolic Blood pressure (office) change after 1 month
Clinical BP on 3 occasions, SBP and BP will be assessed. Mean BP calculated as DBP+1/3(SBP-DBP)
Mean Blood pressure (office)
Clinical BP on 3 occasions, SBP and BP will be assessed. Mean BP calculated as DBP+1/3(SBP-DBP)
Catecholamines (epinephrine)
24h urine samples will be collected and acidified with acetic acid, stored at -20°C until analysis. Catecholamines (epinephrine, norepinephrine, and dopamine) will be measured in one milliliter of urine by high-performance liquid chromatography with electrochemical detection (Coularray Detector, ESA Dionex, Chelmsford, USA).
Norepinephrine)
24h urine samples will be collected and acidified with acetic acid, stored at -20°C until analysis. Catecholamines (epinephrine, norepinephrine, and dopamine) will be measured in one milliliter of urine by high-performance liquid chromatography with electrochemical detection (Coularray Detector, ESA Dionex, Chelmsford, USA).
Dopamine (Catecholamine)
24h urine samples will be collected and acidified with acetic acid, stored at -20°C until analysis. Catecholamines (epinephrine, norepinephrine, and dopamine) will be measured in one milliliter of urine by high-performance liquid chromatography with electrochemical detection (Coularray Detector, ESA Dionex, Chelmsford, USA).
High-frequency component of Heart rate variability
We will use these mathematical methods to analyze a signal over time: temporal analysis, Fourier transformation and wavelet transformation.
High-frequency (HF) translates fluctuations in parasympathetic activity to cardiac destination, modulated by ventilatory characteristics (frequency, courant volume).
Low frequency component of Heart rate variability
We will use these mathematical methods to analyze a signal over time: temporal analysis, Fourier transformation and wavelet transformation.
Low frequency (LF) is classically considered to reflect the activity of the sympathetic system rather than the parasympathetic system.
24 hours Diastolic blood pressure change (AMBP)
ambulatory measurements over 24h
24 hours Mean Blood pressure (AMBP)
ambulatory measurements over 24h
Full Information
NCT ID
NCT03428516
First Posted
January 17, 2018
Last Updated
December 26, 2019
Sponsor
University Hospital, Grenoble
Collaborators
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior., ResMed, Agir pour les maladies chroniques
1. Study Identification
Unique Protocol Identification Number
NCT03428516
Brief Title
Decrease Obstructive Sleep Apnea (OSA) Sympathetic Tone : Impact of APAP vs CPAP
Acronym
APAP-CPAP
Official Title
Decrease in Sympathetic Tone in OSA Patients: Is CPAP More Effective Than APAP ?
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2018 (Actual)
Primary Completion Date
January 1, 2022 (Anticipated)
Study Completion Date
January 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Grenoble
Collaborators
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior., ResMed, Agir pour les maladies chroniques
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The present study aims to compare muscle sympathetic neural activity by microneurography after one month treatment of fixed versus auto-adjusting CPAP treatment and its impact on arterial blood pressure
Detailed Description
Background: Sleep apnea syndrome (SAS) currently affects 10% of general population. It is characterized by the occurrence during the sleep of the upper airways closure which cause repeated asphyxia. It is a public health problem due to its cardiometabolic complications. Indeed, the absence of SAS treatment increases cardiovascular mortality by 12% at 10 years.
The main physiopathological mechanism is the activation of cardiovascular sympathetic control (the short-term regulation of blood pressure which bring in the sympathetic nervous system) An exposure to intermittent chronic hypoxia (caused by SAS) bring an increased of muscle sympathetic nerve activity (MSNA) contributing to elevated blood pressure Continuous Positive Airway Pressure (CPAP) can partly reduce this risk by decreasing elevation of blood pressure caused by the SAS. It has recently been demonstrated that all CPAP devices are not equivalent. Indeed, the auto-adjusted CPAP treatment induces a reduction in blood pressure lower than the reference treatment fixed CPAP.
To this extent it is interesting to conduct a new randomized trial comparing these two treatments with vascular sympathetic tone. This will be assessed by peroneal microneurography recording.
Objective: Compare Muscle Sympathetic Neural Activity (MSNA) by microneurography after one month of fixed versus auto-adjusted CPAP treatment in OSA patients naive from pressure therapy Methods: Prospective study, single-site, randomized, double-blind, parallel, one month controlled trial. After the diagnosis of sleep apnea, patients will be randomized for one month treatment with fixed ou auto-adjusting CPAP. Measurements of MSNA, heart rate variability and catecholamines will be held before and after treatment.
An interim analysis will be performed after the inclusion of 24 patients based on group sequential design
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea Syndromes
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
68 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Fixed CPAP
Arm Type
Experimental
Arm Description
CPAP always deliver air with the same pressure
Arm Title
Auto-adjusting CPAP
Arm Type
Active Comparator
Arm Description
Auto-CPAP changes the pressure delivered depending on events detected at any time (apnea, hypopnea …) and applies the lowest pressure required to eliminate events.
Intervention Type
Device
Intervention Name(s)
Fixed CPAP
Intervention Description
CPAP is a device that applies continous fixed positive pressure to the airways in order to keep them opened during sleep
Intervention Type
Device
Intervention Name(s)
Auto-adjusting CPAP
Intervention Description
Auto-adjusting CPAP is a device that applies auto-adjusting continous positive pressure to the airways in order to keep them opened during sleep
Primary Outcome Measure Information:
Title
Sympathetic tone (MSNA)
Description
Change from Baseline Sympathetic tone at 1 months
Time Frame
Change from baseline after one month of intervention
Secondary Outcome Measure Information:
Title
24 hours Systolic Blood pressure (AMBP)
Description
Change from Baseline in 24 hours ambulatory systolic blood pressure
Time Frame
Change from baseline after one month of intervention
Title
Systolic Blood pressure (office)
Description
Clinical BP on 3 occasions, SBP and BP will be assessed. Mean BP calculated as DBP+1/3(SBP-DBP)
Time Frame
Change from baseline after one month of intervention
Title
Diastolic Blood pressure (office) change after 1 month
Description
Clinical BP on 3 occasions, SBP and BP will be assessed. Mean BP calculated as DBP+1/3(SBP-DBP)
Time Frame
Change from baseline after one month of intervention
Title
Mean Blood pressure (office)
Description
Clinical BP on 3 occasions, SBP and BP will be assessed. Mean BP calculated as DBP+1/3(SBP-DBP)
Time Frame
Change from baseline after one month of intervention
Title
Catecholamines (epinephrine)
Description
24h urine samples will be collected and acidified with acetic acid, stored at -20°C until analysis. Catecholamines (epinephrine, norepinephrine, and dopamine) will be measured in one milliliter of urine by high-performance liquid chromatography with electrochemical detection (Coularray Detector, ESA Dionex, Chelmsford, USA).
Time Frame
Change from baseline after one month of intervention
Title
Norepinephrine)
Description
24h urine samples will be collected and acidified with acetic acid, stored at -20°C until analysis. Catecholamines (epinephrine, norepinephrine, and dopamine) will be measured in one milliliter of urine by high-performance liquid chromatography with electrochemical detection (Coularray Detector, ESA Dionex, Chelmsford, USA).
Time Frame
Change from baseline after one month of intervention
Title
Dopamine (Catecholamine)
Description
24h urine samples will be collected and acidified with acetic acid, stored at -20°C until analysis. Catecholamines (epinephrine, norepinephrine, and dopamine) will be measured in one milliliter of urine by high-performance liquid chromatography with electrochemical detection (Coularray Detector, ESA Dionex, Chelmsford, USA).
Time Frame
Change from baseline after one month of intervention
Title
High-frequency component of Heart rate variability
Description
We will use these mathematical methods to analyze a signal over time: temporal analysis, Fourier transformation and wavelet transformation.
High-frequency (HF) translates fluctuations in parasympathetic activity to cardiac destination, modulated by ventilatory characteristics (frequency, courant volume).
Time Frame
Change from baseline after one month of intervention
Title
Low frequency component of Heart rate variability
Description
We will use these mathematical methods to analyze a signal over time: temporal analysis, Fourier transformation and wavelet transformation.
Low frequency (LF) is classically considered to reflect the activity of the sympathetic system rather than the parasympathetic system.
Time Frame
Change from baseline after one month of intervention
Title
24 hours Diastolic blood pressure change (AMBP)
Description
ambulatory measurements over 24h
Time Frame
Change from baseline after one month of intervention
Title
24 hours Mean Blood pressure (AMBP)
Description
ambulatory measurements over 24h
Time Frame
Change from baseline after one month of intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patient with OSA (AHI ≥20 / h)
patient with daytime sleepiness
naive of any pressure treatment of OSA
patient able to provide written informed consent
not a vulnerable person or legally protected adult.
Exclusion Criteria:
pregnancy
Person deprived of liberty or subject to a legal protection measure.
Patient with serious heart failure (According to investigator judgment)
patient with central sleep apnea index above 20% of AHI
Patient with a significant intercurrent pathology that can influence the results. (According to investigator judgment).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marie Peeters, MD, PhD
Phone
+33476762965
Email
mpeeters@chu-grenoble.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Erika Treptow, MD, PhD
Phone
+33664822293
Email
erikatpw@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Renaud Tamisier, MD, PhD
Organizational Affiliation
University Grenoble Alps
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Grenoble Alpes
City
Grenoble
ZIP/Postal Code
38000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Renaud Tamisier
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
27091542
Citation
Pepin JL, Tamisier R, Baguet JP, Lepaulle B, Arbib F, Arnol N, Timsit JF, Levy P. Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial. Thorax. 2016 Aug;71(8):726-33. doi: 10.1136/thoraxjnl-2015-207700. Epub 2016 Apr 18.
Results Reference
background
PubMed Identifier
30948567
Citation
Treptow E, Pepin JL, Bailly S, Levy P, Bosc C, Destors M, Woehrle H, Tamisier R. Reduction in sympathetic tone in patients with obstructive sleep apnoea: is fixed CPAP more effective than APAP? A randomised, parallel trial protocol. BMJ Open. 2019 Apr 4;9(4):e024253. doi: 10.1136/bmjopen-2018-024253.
Results Reference
derived
Learn more about this trial
Decrease Obstructive Sleep Apnea (OSA) Sympathetic Tone : Impact of APAP vs CPAP
We'll reach out to this number within 24 hrs